BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 116867
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.116867
Table 2 Summary of outcomes in patients with and without post-transjugular intrahepatic portosystemic shunt rebleeding before and after propensity score matching
Characteristics
Before PSM
After PSM
Total (n = 1782)
No post-TIPS rebleeding (n = 1436)
Post-TIPS rebleeding (n = 346)
P value
SMD
Total (n = 1026)
No post-TIPS rebleeding (n = 682)
Post-TIPS rebleeding (n = 344)
P value
SMD
Overt hepatic encephalopathy599 (33.6)466 (32.5)133 (38.4)0.0400.125349 (34.0)218 (32.0)131 (38.1)0.0600.128
All-cause death530 (29.7)390 (27.2)140 (40.5)< 0.0010.284324 (31.6)184 (27.0)140 (40.7)< 0.0010.293
Liver-related death429 (24.1)306 (21.3)123 (35.5)< 0.0010.320270 (26.3)147 (21.6)123 (35.8)< 0.0010.318


Write to the Help Desk